scholarly article | Q13442814 |
P50 | author | Pier Alberto Bertazzi | Q30004136 |
Anna Grazia Recchia | Q37837458 | ||
Sonia Fabris | Q39052038 | ||
Valentina Bollati | Q40951527 | ||
Manlio Ferrarini | Q42322785 | ||
Giovanna Cutrona | Q54323503 | ||
Agostino Cortelezzi | Q56461136 | ||
Antonino Neri | Q56850455 | ||
Mirjam Hoxha | Q75155238 | ||
P2093 | author name string | Luca Agnelli | |
Fortunato Morabito | |||
Massimo Gentile | |||
Serena Matis | |||
P2860 | cites work | POT1 as a terminal transducer of TRF1 telomere length control | Q24302841 |
The human Rap1 protein complex and modulation of telomere length | Q24337452 | ||
The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats | Q24339608 | ||
Telomere measurement by quantitative PCR | Q24529938 | ||
Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis | Q24675780 | ||
Genomic aberrations and survival in chronic lymphocytic leukemia | Q28141442 | ||
Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT) | Q28190909 | ||
Chronic lymphocytic leukemia | Q28236621 | ||
Protein composition of catalytically active human telomerase from immortal cells | Q28295708 | ||
Telomeres shorten during ageing of human fibroblasts | Q29547357 | ||
How shelterin protects mammalian telomeres | Q29615744 | ||
Replication protein A is an independent prognostic indicator with potential therapeutic implications in colon cancer | Q33278718 | ||
The expression of gene transcripts of telomere-associated genes in human breast cancer: correlation with clinico-pathological parameters and clinical outcome | Q33290215 | ||
Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia | Q33310158 | ||
Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis | Q33534356 | ||
CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. | Q33956997 | ||
T-loop assembly in vitro involves binding of TRF2 near the 3' telomeric overhang | Q34082359 | ||
Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations | Q34264324 | ||
Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis | Q34535672 | ||
Cancer chromosomes going to POT1 | Q34688221 | ||
Telomere length modulation in human astroglial brain tumors | Q34731430 | ||
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia. | Q34973576 | ||
Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes | Q35643026 | ||
From RPA to BRCA2: lessons from single-stranded DNA binding by the OB-fold | Q35753202 | ||
Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia | Q37179155 | ||
Walking the walk from genes through telomere maintenance to cancer risk | Q37860824 | ||
Epigenetic regulation of telomeres in human cancer. | Q39944681 | ||
Alterations in DNA methylation may play a variety of roles in carcinogenesis | Q40410595 | ||
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia. | Q44447816 | ||
Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia | Q47812640 | ||
A clinical staging system for chronic lymphocytic leukemia: prognostic significance. | Q50994335 | ||
Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients. | Q51039630 | ||
Telomeres and chromosomal instability in chronic lymphocytic leukemia. | Q54491927 | ||
Telomere length, molecular cytogenetic findings, and immunophenotypic features in previously untreated patients with B-chronic lymphocytic leukemia. | Q54683825 | ||
ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. | Q55036524 | ||
Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome | Q58276318 | ||
Telomeres and prognosis in patients with chronic lymphocytic leukaemia | Q60345319 | ||
Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas | Q74083209 | ||
Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients | Q79777424 | ||
Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia | Q80112597 | ||
Telomere length, cigarette smoking, and bladder cancer risk in men and women | Q80117490 | ||
Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status | Q81474867 | ||
Telomeric damage in early stage of chronic lymphocytic leukemia correlates with shelterin dysregulation | Q83484155 | ||
P433 | issue | 7 | |
P921 | main subject | lymphocyte | Q715347 |
P304 | page(s) | 612-621 | |
P577 | publication date | 2014-04-04 | |
P1433 | published in | Genes, Chromosomes and Cancer | Q5532697 |
P1476 | title | Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia | |
P478 | volume | 53 |
Q42042759 | 3R gene expression in chronic lymphocytic leukemia reveals insight into disease evolution |
Q26738706 | Aberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development? |
Q42371573 | Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia |
Q28389928 | Association between Long Interspersed Nuclear Element-1 Methylation and Relative Telomere Length in Wilms Tumor |
Q57171710 | DNA Methylation of Telomere-Related Genes and Cancer Risk |
Q35772403 | Differential Expression of Non-Shelterin Genes Associated with High Telomerase Levels and Telomere Shortening in Plasma Cell Disorders |
Q33860001 | Dysregulation of H/ACA ribonucleoprotein components in chronic lymphocytic leukemia |
Q37225819 | Genetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic Leukemia |
Q40341051 | Hypoxia pathway genetic variants predict survival of non-small-cell lung cancer patients receiving platinum-based chemotherapy |
Q47635411 | Identifying the biomarker potential of telomerase activity and shelterin complex molecule, telomeric repeat binding factor 2 (TERF2), in multiple myeloma |
Q89220608 | Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia |
Q38784976 | Prognostic role of telomere length in malignancies: A meta-analysis and meta-regression |
Q42348459 | Role of miR-15a/miR-16-1 and the TP53 axis in regulating telomerase expression in chronic lymphocytic leukemia |
Q40485655 | T-cell acute lymphoblastic leukemia in infants has distinct genetic and epigenetic features compared to childhood cases |
Q42250056 | Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A. |
Q52941092 | Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia. |
Q50900368 | Telomere shortening, TP53 mutations and deletions in chronic lymphocytic leukemia result in increased chromosomal instability and breakpoint clustering in heterochromatic regions. |
Q36093789 | Telomere status in chronic lymphocytic leukemia with TP53 disruption. |
Q54980026 | The MRE11-RAD50-NBS1 Complex Conducts the Orchestration of Damage Signaling and Outcomes to Stress in DNA Replication and Repair. |
Q64979971 | Variability within the human TERT gene, telomere length and predisposition to chronic lymphocytic leukemia. |
Q93152904 | miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway |
Search more.